Expand KYTX Menu
KYTX MENU

KYTX Stock Posts


Unusual Option Volume

KYTX Kyverna Therapeutics11.18+1.25 (+12.6%)

Kyverna Therapeutics trades 2,913 contracts. The company has the following event: American Academy of Neurology (AAN) Annual Meeting on Apr 20, 2026. News: Kyverna Presents Longer-Term Phase 2 Data for Miv-cel in Generalized Myasthenia Gravis at AAN, Demonstrating Deep, Durable Responses through 52 Weeks
Unusual Option Volume

KYTX Kyverna Therapeutics7.16-3.08 (-30.1%)

KYTX #KyvernaTherapeutics stock declines -7.1% in premarket,

Premarket Decliner

KYTX Kyverna Therapeutics10.82+2.04+23.2%

Premarket:10.05-0.77 (-7.1%)

Kyverna Therapeutics Announces Proposed Public Offering of Common Stock

Globe NewswireMon, 15-Dec 4:01 PM

KYTX #KyvernaTherapeutics stock declines -5.7% in after hours trading. See the latest news.

After Hours Decliner

KYTX Kyverna Therapeutics10.82+2.04+23.2%

After Hours:10.20-0.62 (-5.7%)

Kyverna Therapeutics Announces Proposed Public Offering of Common Stock

Globe NewswireMon, 15-Dec 4:01 PM

Unusual Option Volume

KYTX Kyverna Therapeutics11.35+2.57 (+29.3%)

Kyverna Therapeutics trades 3,051 contracts. The company has the following event: Kyverna Therapeutics Investor Webcast to Review KYSA-8 Topline Results on Dec 15, 2025. News: Kyverna Therapeutics Announces Positive Topline Data from Registrational KYSA-8 Trial of Miv-cel (KYV-101) in Stiff Person Syndrome
Unusual Option Volume

KYTX Kyverna Therapeutics7.75+0.31 (+4.2%)

Kyverna Therapeutics trades 2,498 contracts. The company has the following event: American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Annual Meeting on Oct 29, 2025.
Market Data Delayed 15 Minutes